Point Of Care Blood Testing Devices Market Trends, Analysis and Forecast through 2032 | FMI
The Point Of Care Blood Testing Devices Market is anticipated to reach US$ 49,973.6 million in value by 2032, up from US$ 15,362.4 million in 2022, growing at a CAGR of 11.3% during the projection period.
Point of care or POC blood testing devices are easy handheld devices which are used to perform various blood tests. Point of care blood testing devices are used to obtain diagnostics test such as protein test, blood metabolites test, hormone blood test, INR or prothrombin test (PT), haemoglobin test and also used to test glucose level in blood. Point of care blood testing devices also referred by many different names such as remote testing device, near-patient testing device and rapid diagnostics devices.
Gain complete access to the report @ https://www.futuremarketinsights.com/reports/point-of-care-blood-testing-devices-market
It can be deduced from the current situations brought about by the pandemic that the production, and supply chain activities have experienced minor hurdles. However, the market is projected to gradually recover post-COVID-19, which will present attractive opportunities for sales across various regions of the world in the following years.
Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Point Of Care Blood Testing Devices Market. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as along with the key takeaways over the forecast.
The team of analysts at Future Market Insights are focussing on research and market study to produce different Point Of Care Blood Testing Devices Market forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Point Of Care Blood Testing Devices Market.
Key Players:
Abaxis
Abbott Laboratories
Accubiotech Co, Ltd.
ACON Laboratories, Inc.
Becton
Dickinson and Company
Biolytical Laboratories
Danaher Corporation (HemoCue)
Siemens Healthineers
Meridian Bioscience, Inc.
Key Segments in the Point of Care Blood Testing Devices Market
By Product Type :
Diabete POC Analyzer
Coaglulation POC Analyzer
POC Blood Analyzer
Hematology POC Reader
By Technology :
Printer Devices
Touch-Screen Devices
Hand-held Devices
By Distribution Channels :
Retail Prices
Hospitals
Clinics
Health Centers
Homecare Settings